Allele-specific wild-type blocker quantitative PCR for highly sensitive detection of rare JAK2 p.V617F point mutation in primary myelofibrosis as an appropriate tool for the monitoring of molecular remission following therapy

Journal of Clinical Pathology

Volumn 63, Issue 4, 2010, Pages 370-372

  Siebolts, Udo ^a,b   Lange, Thoralf ^a   Niederwieser, Dietger ^a   Wickenhauser, Claudia ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE 2;

ALLELE; ARTICLE; BONE MARROW BIOPSY; HUMAN; MONITORING; MYELOID METAPLASIA; PATIENT CARE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SCREENING; SENSITIVITY AND SPECIFICITY; STEM CELL TRANSPLANTATION; WILD TYPE;

ALLELES; BIOPSY; BONE MARROW; EARLY DIAGNOSIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; JANUS KINASE 2; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIMARY MYELOFIBROSIS; RECURRENCE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 77950423036     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2009.069773     Document Type: Article

References (7)

1. Beer PA, Campbell PJ, Scott LM, et al. MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort. Blood 2008;112:141-149
2. Adamson JW, Fialkow PJ, Murphy S, et al. Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med 1976;295:913-916
3. Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005;365:1054-1061 (Pubitemid 40386783)
4. Campbell PJ, Scott LM, Buck G, et al. Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. Lancet 2005;366:1945-1953 (Pubitemid 41713984)
5. Manshouri T, Quintas-Cardama A, Nussenzveig RH, et al. The JAK kinase inhibitor CP-690,550 suppresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation. Cancer Sci 2008;99:1265-1273
6. Dominguez PL, Kolodney MS. Wild-type blocking polymerase chain reaction for detection of single nucleotide minority mutations from clinical specimens. Oncogene 2005;24:6830-6834
7. Latorra D, Arar K, Hurley JM. Design considerations and effects of LNA in PCR primers. Mol Cell Probes 2003;17:253-259 (Pubitemid 37346175)